Evidence map›Paper›PMID 41633974›Full record

ArticleSignal transduction and targeted therapy2026

Region-resolved proteomic map of the human brain: functional interconnections and neurological implications.

Pei-Pei Zhang, Man-Sheng Li, Jia Zhou, Chu-Hong Zhu, Rui Tang, Zhi-Cheng He, Xiao-Hong Yao, Yi-Fang Ping, Dong-Fang Xiang, Le-Yong Tan and 7 more

Abstract read
In one paragraph

Article in Signal transduction and targeted therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Pei-Pei Zhang *Chongqing Institute of Advanced Pathology and Yu-Yue Scientific Research Center for Pathology, Jinfeng Laboratory, Chongqing, China.
Man-Sheng Li *State Key Laboratory of Proteomics, National Center for Protein Sciences (Beijing), Beijing, China.ORCID http://orcid.org/0000-0002-0778-0965
Jia Zhou *Stem Cell and Regenerative Medicine Lab, National Infrastructures for Translational Medicine and State Key Laboratory for Complex, Severe, and Rare Diseases, Institute of Clinical Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Chu-Hong ZhuDepartment of Anatomy, Third Military Medical University (Army Medical University), Chongqing, China.
Rui TangInstitute of Pathology, Medical Research Center for Glioma, Southwest Cancer Center, the First Affliated Hospital (Southwest Hospital) and School of Basic Medical Sciences, Army Medical University (Third Military Medical University), and the Key Laboratory of Tumor Immunopathology, the Ministry of Education (Third Military Medical University), Chongqing, China.
Zhi-Cheng HeInstitute of Pathology, Medical Research Center for Glioma, Southwest Cancer Center, the First Affliated Hospital (Southwest Hospital) and School of Basic Medical Sciences, Army Medical University (Third Military Medical University), and the Key Laboratory of Tumor Immunopathology, the Ministry of Education (Third Military Medical University), Chongqing, China.
Xiao-Hong YaoInstitute of Pathology, Medical Research Center for Glioma, Southwest Cancer Center, the First Affliated Hospital (Southwest Hospital) and School of Basic Medical Sciences, Army Medical University (Third Military Medical University), and the Key Laboratory of Tumor Immunopathology, the Ministry of Education (Third Military Medical University), Chongqing, China.ORCID http://orcid.org/0000-0002-4689-9141
Yi-Fang PingInstitute of Pathology, Medical Research Center for Glioma, Southwest Cancer Center, the First Affliated Hospital (Southwest Hospital) and School of Basic Medical Sciences, Army Medical University (Third Military Medical University), and the Key Laboratory of Tumor Immunopathology, the Ministry of Education (Third Military Medical University), Chongqing, China.ORCID http://orcid.org/0000-0002-0699-8401
Dong-Fang XiangInstitute of Pathology, Medical Research Center for Glioma, Southwest Cancer Center, the First Affliated Hospital (Southwest Hospital) and School of Basic Medical Sciences, Army Medical University (Third Military Medical University), and the Key Laboratory of Tumor Immunopathology, the Ministry of Education (Third Military Medical University), Chongqing, China.
Le-Yong TanInstitute of Pathology, Medical Research Center for Glioma, Southwest Cancer Center, the First Affliated Hospital (Southwest Hospital) and School of Basic Medical Sciences, Army Medical University (Third Military Medical University), and the Key Laboratory of Tumor Immunopathology, the Ministry of Education (Third Military Medical University), Chongqing, China.
Yu-Jie WangStem Cell and Regenerative Medicine Lab, National Infrastructures for Translational Medicine and State Key Laboratory for Complex, Severe, and Rare Diseases, Institute of Clinical Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Shuai WangInstitute of Pathology, Medical Research Center for Glioma, Southwest Cancer Center, the First Affliated Hospital (Southwest Hospital) and School of Basic Medical Sciences, Army Medical University (Third Military Medical University), and the Key Laboratory of Tumor Immunopathology, the Ministry of Education (Third Military Medical University), Chongqing, China.
Si-Si LiInstitute of Pathology, Medical Research Center for Glioma, Southwest Cancer Center, the First Affliated Hospital (Southwest Hospital) and School of Basic Medical Sciences, Army Medical University (Third Military Medical University), and the Key Laboratory of Tumor Immunopathology, the Ministry of Education (Third Military Medical University), Chongqing, China.
Jie MaState Key Laboratory of Proteomics, National Center for Protein Sciences (Beijing), Beijing, China.ORCID http://orcid.org/0000-0002-8934-922X
Yun-Ping ZhuState Key Laboratory of Proteomics, National Center for Protein Sciences (Beijing), Beijing, China. zhuyunping@ncpsb.org.cn.
Xiu-Wu BianInstitute of Pathology, Medical Research Center for Glioma, Southwest Cancer Center, the First Affliated Hospital (Southwest Hospital) and School of Basic Medical Sciences, Army Medical University (Third Military Medical University), and the Key Laboratory of Tumor Immunopathology, the Ministry of Education (Third Military Medical University), Chongqing, China. bianxiuwu@tmmu.edu.cn.ORCID http://orcid.org/0000-0003-4383-0197
Ling LengStem Cell and Regenerative Medicine Lab, National Infrastructures for Translational Medicine and State Key Laboratory for Complex, Severe, and Rare Diseases, Institute of Clinical Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. lengling@pumch.cn.ORCID http://orcid.org/0000-0002-6519-012X

Funding

Beijing Municipal Science and Technology Commission Z231100007223009Chinese Academy of Medical Sciences (CAMS) 2023-I2M-3-002National Natural Science Foundation of China (National Science Foundation of China) 82341079National Science Foundation of China | Young Scientists Fund 82401595Peking Union Medical College Hospital (PUMCH) 2025-PUMCH-C-016Science and Technology Commission of Shanghai Municipality (Shanghai Municipal Science and Technology Commission) 23YF1423900
6 · The paper itself

Abstract

While progress has been made in transcriptomic profiling of the human brain, functional characterization of brain regions and their interactions on the basis of regional protein expression remains limited. Here, we constructed a proteomic map from thirteen anatomical brain regions of eight cadaver donors to elucidate region-specific protein expression patterns and their implications for brain function. The results underscore the interconnectivity of the four cerebral lobes, suggesting facilitated information integration through large-scale neural networks. We propose a three-module framework (cortical integration module [frontal lobe, temporal lobe, parietal lobe, occipital lobe], limbic-relay network [amygdaloid nucleus, hippocampus, thalamus/hypothalamus], and midline regulatory axis [thalamus/hypothalamus, corpus callosum, ventricles, optic chiasm]) and provide molecular evidence supporting the potential involvement of the midline regulatory axis, brainstem, and cerebellum in higher-order cognitive functions. The midline regulatory axis may play a critical but underexplored role in neurodevelopment, interregional signaling, and structural homeostasis, potentially through efficient synaptic function, energy metabolism, and extracellular matrix integrity. This analysis may enhance the understanding of brain physiology and highlight the need to integrate proteomic and transcriptomic approaches in the study of brain function and neurological disorders.

Indexed as

BrainProteomeProteomicsFemaleHumansMaleNeurodevelopmentProteome

Identifiers

PMID41633974
PMCPMC12868004

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.